GLP-1 Progress Tracker App Track weight trends, progress photos, Journey Cards, dose context, food, side effects, protein, water, and medication-level context in one GLP-1 app
Nine decades of work, and not a single commercial product exists
Check your coverage See whether your GLP-1 medication is covered by your insurance plan
Lipids During the semaglutide trials, improvements in fasting blood lipid profile were observed, predominantly in the group receiving semaglutide 1 mg (see the Pharmacodynamics section for further details)
This mechanistic insight has prompted the exploration of ferroptosis as a therapeutic target, given its potential contribution to dopaminergic neuronal loss and disease progression
Retatrutide: A Triple Agonist Approach to Transformation Discovering the right medication can be a transformative experience